» Authors » Mariusz Wysocki

Mariusz Wysocki

Explore the profile of Mariusz Wysocki including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 146
Citations 459
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Viskochil D, Wysocki M, Learoyd M, Sun P, So K, Evans A, et al.
Neurooncol Adv . 2024 May; 6(1):vdae036. PMID: 38721358
Background: Selumetinib is approved for the treatment of pediatric patients with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN) in multiple countries, including the USA (≥ 2...
2.
Samborska M, Skalska-Sadowska J, Achkar R, Wachowiak J, Derwich K, Czogala M, et al.
Contemp Oncol (Pozn) . 2024 Feb; 27(4):249-254. PMID: 38405205
Introduction: This study aimed to present the clinical features and results of treatment of patients diagnosed with refractory or relapsed acute myeloid leukaemia (AML) in Polish Paediatric Leukaemia/Lymphoma Study Group...
3.
Repczynska A, Julga K, Lorenc A, Skalska-Sadowska J, Wysocki M, Zaucha-Prazmo A, et al.
Adv Clin Exp Med . 2023 Aug; 33(4):361-368. PMID: 37540155
Background: The high sensitivity of cells of Fanconi anemia (FA) patients to DNA cross-linking agents (clastogens), such as mitomycin C (MMC), was used as a screening tool in Polish children...
4.
Grzesk E, Koltan S, Dabrowska A, Urbanczyk A, Maldyk J, Malkowski B, et al.
Front Immunol . 2022 Aug; 13:915986. PMID: 35990691
Hydroa vacciniforme-like lymphoproliferative disorder (HV-LPD) is a cutaneous form of chronic active Epstein-Barrvirus (EBV) infection, which can develop into the extremely rare systemic lymphoma. Patients with Inborn errors of immunity...
5.
Samborska M, Baranska M, Wachowiak J, Skalska-Sadowska J, Thambyrajah S, Czogala M, et al.
Front Oncol . 2022 Jul; 12:935373. PMID: 35875115
Introduction: Myeloid sarcoma (MS) is an extramedullary malignant tumor composed of immature myeloid cells. It occurs in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myeloid leukemia...
6.
Latoch E, Zubowska M, Mlynarski W, Stachowicz-Stencel T, Stefanowicz J, Slawinska D, et al.
Cancer Epidemiol . 2022 Jul; 80:102209. PMID: 35868173
Background: The effect of age on the incidence of late sequelae that occur after anticancer treatment in childhood is still not fully elucidated. In this multicenter study of long-term survivors...
7.
Chargari C, Haie-Meder C, Espenel S, Garcia M, Ben-Arush M, Bolle S, et al.
Int J Radiat Oncol Biol Phys . 2022 Mar; 113(3):602-613. PMID: 35278672
Purpose: Childhood cancer is rare, and treatment is frequently associated with long-term morbidity. Disparities in survival and long-term side effects encourage the establishment of networks to increase access to complex...
8.
Grzesk E, Dabrowska A, Urbanczyk A, Ewertowska M, Wysocki M, Koltan S
Postepy Dermatol Alergol . 2021 Dec; 38(5):873-880. PMID: 34849137
Introduction: Common variable immunodeficiency (CVID) is one of the primary humoral immunodeficiencies. Despite the inborn nature, the first symptoms may appear in both children and adults. It is characterized by...
9.
Koltan S, Koltan A, Soszynska K, Matiakowska K, Morgut-Klimkowska M, Grzesk E, et al.
Cent Eur J Immunol . 2021 Nov; 46(2):210-216. PMID: 34764789
Introduction: Acute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children. The factors predisposing to ALL remain mostly unknown. Natural killer (NK) cells are a component of innate...
10.
Styczynski J, Debski R, Czyzewski K, Gagola K, Marquardt E, Roszkowski K, et al.
In Vivo . 2021 Oct; 35(6):3315-3320. PMID: 34697163
Background/aim: Comparison of transplant outcomes in long-term follow-up of children after total body irradiation (TBI)- or chemotherapy-based conditioning allogeneic hematopoietic cell transplantation (allo-HCT). Patients And Methods: Patients undergoing allo-HCT for...